- Home
- SOTK vs FGEN Comparison
SOTK vs FGEN Comparison
Compare SOTK & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- FGEN
- Stock Information
- Founded
- SOTK 1975
- FGEN 1993
- Country
- SOTK United States
- FGEN United States
- Employees
- SOTK N/A
- FGEN N/A
- Industry
- SOTK Industrial Machinery/Components
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- FGEN Health Care
- Exchange
- SOTK Nasdaq
- FGEN Nasdaq
- Market Cap
- SOTK 52.1M
- FGEN 45.1M
- IPO Year
- SOTK 1987
- FGEN 2014
- Fundamental
- Price
- SOTK $4.61
- FGEN $11.00
- Analyst Decision
- SOTK Hold
- FGEN Strong Buy
- Analyst Count
- SOTK 1
- FGEN 2
- Target Price
- SOTK N/A
- FGEN $146.50
- AVG Volume (30 Days)
- SOTK 50.4K
- FGEN 21.0K
- Earning Date
- SOTK 10-14-2025
- FGEN 11-03-2025
- Dividend Yield
- SOTK N/A
- FGEN N/A
- EPS Growth
- SOTK 6.63
- FGEN N/A
- EPS
- SOTK 0.10
- FGEN N/A
- Revenue
- SOTK $20,607,030.00
- FGEN $7,346,000.00
- Revenue This Year
- SOTK $2.67
- FGEN N/A
- Revenue Next Year
- SOTK $8.20
- FGEN N/A
- P/E Ratio
- SOTK $47.93
- FGEN N/A
- Revenue Growth
- SOTK N/A
- FGEN N/A
- 52 Week Low
- SOTK $3.23
- FGEN $4.50
- 52 Week High
- SOTK $6.05
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- SOTK 59.63
- FGEN 48.74
- Support Level
- SOTK $4.36
- FGEN $10.59
- Resistance Level
- SOTK $4.96
- FGEN $11.27
- Average True Range (ATR)
- SOTK 0.39
- FGEN 0.47
- MACD
- SOTK -0.01
- FGEN 0.01
- Stochastic Oscillator
- SOTK 47.57
- FGEN 49.22
About SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.